Monitor the October 23 vote outcome closely — failure to extend the deadline would likely trigger liquidation and a return of trust proceeds to shareholders, while approval buys time for a deal announcement.
Price Chart
Executive Summary
Oaktree Acquisition Corp. III Life Sciences postponed its extraordinary general meeting from October 16, 2026 to October 23, 2026 to allow more time for proxy solicitation on a proposal to extend the deadline for completing a business combination. The postponement signals difficulty securing shareholder approval for the extension, which is critical to avoiding liquidation.
Key Facts
- General meeting postponed from October 16, 2026 to October 23, 2026.
- Meeting is to vote on extending the date by which OAC must complete an initial business combination.
- Postponement was approved by the extension committee of the board to permit further solicitation and vote of proxies.
- Record date remains September 22, 2026; previously submitted proxies remain valid.
- Shareholders may continue to request withdrawal of redemption of Class A ordinary shares until the rescheduled meeting.
Financial Impact
No financial figures disclosed; the extension proposal is critical to avoid liquidation of the SPAC trust.
Risk Factors
- Shareholders may vote against the extension, leading to liquidation of the SPAC.
- Further postponements may signal inability to secure a deal within the extended timeline.
- Redemption requests could reduce trust assets if the extension is approved.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-423329 |
| Document: 0001193125-26-423329-index-headers.html | 0001193125-26-423329 |
| Document: 0001193125-26-423329-index.html | 0001193125-26-423329 |
| Document: 0001193125-26-423329.txt | 0001193125-26-423329 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $10.71 | awaiting T+1 | — | $10.68 (+0.28%) |
Oct 16, 2026 10d ago | DEFA14A | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 16, 2026 10d ago | 8-K | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.68 (+0.19%) |
Oct 15, 2026 11d ago | DEFA14A | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 15, 2026 11d ago | 8-K | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.68 (−0.28%) |
Oct 2, 2026 24d ago | DEF 14A | $10.76 $10.76 | · 0.00% | ▼ −0.55% | $10.68 (−0.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers